In addition, we confirmed for the first time, to our knowledge, that downregulation of ZSCAN18 with hypermethylation in CpG44.45 is associated with poor survival in primary GC; this finding suggests that ZSCAN18 may serve as a biomarker of poor prognosis [15–17]. The gene discussed is ZSCAN18; the disease is gastric cancer.